FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role (role) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only atezolizumab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only brigatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing brigatinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing brigatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only brigatinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Capmatinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Capmatinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing capmatinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only capmatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Capmatinib 200 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Capmatinib 150 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing selpercatinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only selpercatinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Selpercatinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing selpercatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely selpercatinib 40 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Selpercatinib 80 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ripretinib 50 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ripretinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only ripretinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ripretinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing ripretinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing erlotinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Erlotinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Erlotinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Erlotinib (as erlotinib hydrochloride) 25 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Erlotinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Gemtuzumab ozogamicin only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only gemtuzumab ozogamicin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing gemtuzumab ozogamicin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing gemtuzumab ozogamicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lurbinectedin-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lurbinectedin only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing lurbinectedin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely lurbinectedin 4 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Lurbinectedin only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tazemetostat (as tazemetostat hydrobromide) 200 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely selinexor 20 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Brexucabtagene autoleucel-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Brexucabtagene autoleucel only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Brexucabtagene autoleucel-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only brexucabtagene autoleucel in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Brigatinib 30 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely brigatinib 180 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely brigatinib 90 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely afatinib (as afatinib dimaleate) 50 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing afatinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Afatinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Afatinib (as afatinib dimaleate) 20 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Afatinib (as afatinib dimaleate) 30 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Afatinib (as afatinib dimaleate) 40 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Afatinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only afatinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Binimetinib 15 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Binimetinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing binimetinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing binimetinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Binimetinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely capecitabine 300 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Capecitabine 500 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Capecitabine 150 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing capecitabine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing capecitabine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Capecitabine only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only capecitabine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cabozantinib (as cabozantinib s-malate) 20 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely cabozantinib (as cabozantinib s-malate) 40 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely cabozantinib (as cabozantinib s-malate) 60 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing vinorelbine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing vinorelbine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only vinorelbine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Vinorelbine only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Vinflunine-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Vinflunine only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing vinflunine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Vinflunine only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing vincristine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing vincristine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely vincristine sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only vincristine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only vincristine liposome (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Vincristine only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only vincristine liposome in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only vindesine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Vindesine only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing vindesine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing vindesine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing aclarubicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only aclarubicin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing aclarubicin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Aclarubicin only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Aflibercept-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing aflibercept (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only aflibercept in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Aflibercept only product Plays role True Antineoplastic therapeutic role Inferred relationship Some

Start Previous Page 3 of 17 Next End

This concept is not in any reference sets

Back to Start